Ypsomed Holding AG, Roche Holding AG, Eli Lilly & Co., Novo Nordisk A/S

    Bonus Amount: 1,200.00 CHF  |  Currency: CHF  |  Maturity: 21/09/2026

    %
    CHF Nominal

    %
    CHF Nominal

    Product Overview

    Key figures

    Bonus amount of denomination
    120.00%
    Denomination
    1,000.00 CHF
    Distance to Barrier

    Life Cycle

    • Initial Fixing
    • First trading day
    • Barrier hit
    • Today
    • Last trading date
    • Final fixing
    • Redemption
    GraphUnderlyingPrice (indicative)Last Closing Price (indicative)Performance
    -Eli Lilly & Co.Price (indicative)
    Last Closing Price (indicative)744.6177 USDPerformance-6.66%
    -Novo Nordisk A/SPrice (indicative)
    Last Closing Price (indicative)591.7457 DKKPerformance+0.59%
    -Roche Holding AGPrice (indicative)
    Last Closing Price (indicative)263.2336 CHFPerformance0.00%
    -Ypsomed Holding AGPrice (indicative)
    Last Closing Price (indicative)324.5763 CHFPerformance+0.61%